At least a quarter of people with heart disease don't take vital medicines they have been prescribed to prevent heart attacks and strokes.

Results of a study reported at the Royal Pharmaceutical Society's annual event, the British Pharmaceutical Conference in Manchester, confirm that doctors need to pay more attention to the way patients take their medicines, in line with recommendations in recent NICE guidance.

In a study of 472 patients on the heart disease register of a large GP practice in North East England, 29% of patients failed to take medicines to prevent strokes and heart attacks regularly enough and 23% missed doses of statins to reduce their cholesterol. Women were slightly more likely to take their medicines on schedule than men, as were older patients and those taking larger numbers of medicines.

"Simply prescribing a drug is not enough. Doctors and other members of the primary care team, such as pharmacists, need to work with patients so they understand the importance of taking their medicines in the right dose, at the right time," concluded pharmacist Dr Wasim Baqir, from The Village Green Surgery, Sunderland.

In its guidelines on Medicines Adherence published earlier this year, NICE recommended a patient-centred approach to address the widespread problem of poor medicine taking1. It stressed that healthcare professionals should adapt their consulting style to individual patients, involve them in making decisions about medication, and address practical issues such as forgetting to take medicines or concerns about side effects.

References

1. National Institute for Health and Clinical Excellence: Medicines Adherence, (2009), London.

Patient adherence to prescribed medication was calculated by comparing the number of repeat prescriptions requested by the patient in a 12 month period with that required for medication to be taken correctly. Good adherence to medication was defined as requests for 85%-115% of necessary repeat prescriptions.

The British Pharmaceutical Conference is the flagship annual conference of the RPSGB and is now in its 147th year. This year, it takes place in Manchester from Sunday 6 September - Wednesday 9 September inclusive. Around 1000 pharmacists from the UK and internationally will convene to debate practice issues and scientific developments affecting the profession during the four-day event.

Research released at BPC is published in the Journal of Pharmacy and Pharmacology.

Source
Royal Pharmaceutical Society of Great Britain